IDEXX Laboratories (IDXX) Stock Jumps 19% on Raised Forecast

IDXX shares surged over 19% Monday after Reuters reported the company raised its forecast on strength in diagnostics.

IDEXX Laboratories (IDXX) is up 19.09% at $656.45 in Monday's session, as Reuters reported the company raised its forecast, betting that diagnostics revenue can offset softer veterinary visits. The move came during regular trading, with the stock ranging between $620.20 and $662.98 so far in the session.

Idexx Laboratories (IDXX) today
MeasureValue
Price$656.45
Change from the prior close+19.09%
Prior close$551.21
Today's range$620.20 – $662.98
52-week range$500.61 – $769.98
Market value$51.72 billion

Source: Stock quote during the regular session · as of November 2, 2026 at 12:00 PM ET

What was reported

Reuters reported that IDEXX Laboratories raised its forecast, with the company wagering that its diagnostics business could make up for a decline in veterinary clinic visits. Separate from confirmed reporting, traders on X have been discussing what they describe as a stronger-than-anticipated earnings release paired with an upward revision to guidance, with conversation focused on recurring revenue from diagnostic testing holding up even as visit volumes in the United States softened. Some participants in that conversation were also said to be weighing the stock's valuation after the jump and comparing its advance to weakness seen elsewhere in technology shares, though none of this is confirmed reporting.

Its suppliers and customers

Company filings list four organizations tied to IDEXX Laboratories: Thermo Fisher Scientific, Inc. (TMO) as a supplier, Ortho as a supplier, and Mars, Incorporated along with National Veterinary Associates as customers. Thermo Fisher Scientific is trading down 1.91% today, while Ortho, Mars, and National Veterinary Associates have no available quotes; none of these moves should be read as connected to IDEXX's advance.

Suppliers and customers of Idexx Laboratories, and how they are trading
CompanyRoleStockToday
Thermo Fisher Scientific, Inc.SupplierTMO-1.91%
OrthoSupplierNot listed—
Mars, IncorporatedCustomerNot listed—
National Veterinary AssociatesCustomerNot listed—

Source: Relationships named in company filings (SEC 10-K annual report); stock quotes · as of November 2, 2026 at 12:00 PM ET · A supplier or customer moving the same day is not evidence that one move caused the other.

Sources

How this was made

Built from WiseView and market data, with reporting from the sources above. Drafted with AI assistance and reviewed by an editor before publishing. How this report is made

For information only, not investment advice.

More from the desk

Follow TMO and IDXX in the terminal.

Membership details

14-day free trial · no card needed · nothing to cancel.

Then $83/mo billed annually — $997 once a year.

WiseView provides market data and research tools for educational purposes. Nothing here is investment advice. Past performance does not predict future results.